Top Buy
| Security | Buy ▼ | Sell | Buy (1M) | Sell (1M) | Price | Target price | Potential |
|---|---|---|---|---|---|---|---|
| Alnylam Pharmace. | 36 | 0 | 2 | 0 | €138.25 | €236.30 | 70.921% |
| Neurocrine Bioscience | 29 | 0 | 8 | 0 | €130.00 | €140.60 | 8.157% |
| Tenet Healthcare | 28 | 0 | 5 | 0 | €120.00 | €124.47 | 3.728% |
| Iovance Biotherapeutics Inc. | 20 | 3 | 1 | 0 | €9.51 | €22.78 | 139.589% |
| United Therapeutics | 19 | 0 | 4 | 0 | €255.80 | €287.40 | 12.354% |
| Icon plc | 18 | 0 | 3 | 0 | €296.00 | €319.67 | 7.996% |
| Exelixis Inc. | 18 | 0 | 3 | 0 | €18.89 | €26.01 | 37.709% |
| Ultragenyx Pharmaceutical Inc. | 17 | 1 | 2 | 0 | €37.40 | €84.74 | 126.588% |
| Merit Medical Systems | 17 | 0 | 4 | 0 | €74.50 | €86.90 | 16.640% |
| Insulet Corp. | 16 | 0 | 2 | 0 | €158.00 | €215.54 | 36.416% |
| PTC Therapeutics Inc. | 15 | 7 | 3 | 2 | €34.00 | €41.81 | 22.982% |
| Halozyme Therapeutics Inc. | 15 | 0 | 3 | 0 | €40.65 | €47.17 | 16.039% |
| Arrowhead Pharmaceuticals Inc. | 14 | 2 | 2 | 0 | €22.83 | €52.03 | 127.880% |
| Amedisys Inc. | 14 | 0 | 1 | 0 | €88.00 | €92.26 | 4.841% |
| Repligen Corp. | 13 | 0 | 1 | 0 | €146.90 | €184.76 | 25.773% |
| Alkermes plc | 13 | 2 | 1 | 0 | €22.20 | €35.14 | 58.281% |
| Molina Healthcare | 12 | 1 | 1 | 0 | €315.30 | €366.73 | 16.311% |
| CONMED Corp. | 11 | 1 | 4 | 0 | €69.00 | €106.18 | 53.883% |
| Charles River Labs Intl | 10 | 0 | 1 | 0 | €201.40 | €248.57 | 23.421% |
| Bio-Techne Corp. | 10 | 0 | 2 | 0 | €77.00 | €75.94 | -1.382% |
| Xencor Inc. | 10 | 1 | 1 | 0 | €21.40 | €32.58 | 52.238% |
| Medpace Holdings Inc | 9 | 0 | 2 | 0 | €361.30 | €421.61 | 16.691% |
| Ensign Group Inc. | 9 | 0 | 1 | 0 | €110.00 | €116.99 | 6.357% |
| LivaNova plc | 9 | 0 | 3 | 0 | €55.50 | €66.59 | 19.987% |
| QIAGEN NV | 9 | 0 | 0 | 0 | €40.47 | €47.44 | 17.223% |